Position in HLN
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$174,545
-$4,463 QoQ
Shares Held
18,708
+4.6% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#305
of 639 holders
Holding Since
Sep 2022
16 quarters on record
Voting authority
Sole 0%
Shared 100%
None 0%
Common Shares in HLN Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026Invesco Ltd. holds $1,945,758,306 across 45 Drug Manufacturers - Specialty & Generic names. HLN ranks #40 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ZTS |
Zoetis Inc.
|
5,523,018 | $396,884,069 | |
| 2 | VTRS |
Viatris Inc
|
20,771,275 | $329,847,840 | |
| 3 | UTHR |
UNITED THERAPEUTICS Corp
|
473,109 | $256,344,645 | |
| 4 | NBIX |
Neurocrine Biosciences Inc
|
1,077,317 | $181,571,000 | |
| 5 | ELAN |
Elanco Animal Health Inc
|
5,306,326 | $130,588,679 | |
| 6 | TEVA |
Teva Pharmaceutical Industries Ltd
|
3,430,011 | $116,208,767 | |
| 7 | INDV |
Indivior Pharmaceuticals, Inc.
|
1,842,983 | $75,617,590 | |
| 8 | COLL |
Collegium Pharmaceutical, Inc
|
1,882,499 | $68,146,461 |
All Filings in HLN
Export CSV
16 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $174,545 | 18,708 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $179,008 | 17,883 | Shares | Defined | 2026-05-12 | |
| 2025-12-31 | $215,959 | 21,361 | Shares | Defined | 2026-02-19 | |
| 2025-09-30 | $6,125,765 | 682,917 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $15,643,963 | 1,508,579 | Shares | Defined | 2025-08-13 | |
| 2025-03-31 | $13,860,279 | 1,346,966 | Shares | Defined | 2025-05-12 | |
| 2024-12-31 | $15,478,802 | 1,622,516 | Shares | Defined | 2025-02-13 | |
| 2024-09-30 | $18,114,821 | 1,712,176 | Shares | Defined | 2024-11-12 | |
| 2024-06-30 | $14,368,699 | 1,739,552 | Shares | Defined | 2024-08-13 | |
| 2024-03-31 | $18,844,047 | 2,219,558 | Shares | Defined | 2024-05-14 | |
| 2023-12-31 | $20,687,166 | 2,513,629 | Shares | Defined | 2024-02-13 | |
| 2023-09-30 | $22,329,772 | 2,680,645 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $23,705,812 | 2,828,856 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $23,761,302 | 2,919,079 | Shares | Defined | 2023-05-12 | |
| 2022-12-31 | $13,672,736 | 1,709,092 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $2,147,151 | 352,570 | Shares | Defined | 2022-11-14 | |
| No filing history on record for this holder in this stock. | ||||||